Unknown NA INTERVENTIONAL 2-arm NCT04358146

Study on the Efficacy and Tolerance of a New Anti-regurgitation Infant Formula (STELLAR) (STELLAR)

Study on the Efficacy and Tolerance of a New Anti-regurgitation Infant Formula: a Double-blind, Randomized, Controlled, International, Multi-centric Clinical Trial

Sponsor: Statitec

Conditions Gastroesophageal Reflux in Children

Interventions Experimental Infant formula Infant formula thickened with locust bean gum

Updated 5 times since 2020 Last updated: Apr 21, 2020 Started: Jul 1, 2020 Primary completion: Jan 1, 2022 Completion: Mar 1, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Gastroesophageal Reflux in Children, this trial is ongoing. The trial is conducted by Statitec and has accumulated 5 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
May 2022 — Jul 2024 [monthly]

Unknown Status NA

Status: Not Yet Recruiting → Unknown Status
Jan 2021 — May 2022 [monthly]

Not Yet Recruiting NA
May 2020 — Jan 2021 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Statitec
United Pharmaceuticals

Data source: United Pharmaceuticals

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.